Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004102966 | SCV003566730 | uncertain significance | not specified | 2021-07-20 | criteria provided, single submitter | clinical testing | The c.571G>A (p.E191K) alteration is located in exon 4 (coding exon 4) of the NPEPL1 gene. This alteration results from a G to A substitution at nucleotide position 571, causing the glutamic acid (E) at amino acid position 191 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |